Literature DB >> 15891925

Metachronous second primary tumours in the aerodigestive tract in patients with early stage head and neck squamous cell carcinomas.

Xavier León1, María Del Prado Venegas, César Orús, Kasia Kolañczak, Jacinto García, Miquel Quer.   

Abstract

Early-stage head and neck carcinomas can usually be controlled with the appropriate treatment. In these patients, the long-term prognosis mainly depends on second metachronous malignancies, frequently in the aerodigestive tract. Our study aims to identify risk factors for the appearance of second tumours in this group of patients with early head and neck cancer. Of 949 patients included in the study, 189 (20%) developed a metachronous second primary malignancy, most frequently in the aerodigestive tract. Independent risk factors associated with second tumours were heavy alcohol use and the location of the index tumour in the oropharynx. Compared to non-drinkers, heavy drinkers (>80 g/day) presented a 1.8-times higher risk of a second tumour (CI 95%: 1.01-3.50). Patients with oropharyngeal tumours had a 2.15-higher risk than patients with oral cavity tumours (CI 95%: 1.03-4.47). Recursive partitioning analysis was used to characterise two risk groups for second tumours. The low-risk group included patients over 75 years and patients with low levels of carcinogen use. It comprised 171 patients (18%) with a 5.3% frequency of second tumours. The high-risk group accounted for 80% of the patients (n = 778), and the rate of second neoplasms was 16.3%. Classification of the patients according to the mentioned variables allows us to focus follow-up and prevention efforts on high-risk patients.

Entities:  

Mesh:

Year:  2005        PMID: 15891925     DOI: 10.1007/s00405-005-0922-5

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  14 in total

1.  Metachronous second primary cancers after successful partial laryngectomy for invasive squamous cell carcinoma of the true vocal cord.

Authors:  Ollivier Laccourreye; France David Veivers; Stéphane Hans; France Daniel Brasnu; Dominique Garcia; France Laurent Laccourreye
Journal:  Ann Otol Rhinol Laryngol       Date:  2002-03       Impact factor: 1.547

2.  Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.

Authors:  J G Spector; D G Sessions; B H Haughey; K S Chao; J Simpson; S El Mofty; C A Perez
Journal:  Laryngoscope       Date:  2001-06       Impact factor: 3.325

3.  Stage I (T1 N0 M0) squamous cell carcinoma of the laryngeal glottis: therapeutic results and voice preservation.

Authors:  J G Spector; D G Sessions; K S Chao; B H Haughey; J M Hanson; J R Simpson; C A Perez
Journal:  Head Neck       Date:  1999-12       Impact factor: 3.147

4.  The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.

Authors:  F R Khuri; E S Kim; J J Lee; R J Winn; S E Benner; S M Lippman; K K Fu; J S Cooper; E E Vokes; R M Chamberlain; B Williams; T F Pajak; H Goepfert; W K Hong
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-08       Impact factor: 4.254

5.  Mutagen sensitivity in patients with head and neck cancers: a biologic marker for risk of multiple primary malignancies.

Authors:  S P Schantz; M R Spitz; T C Hsu
Journal:  J Natl Cancer Inst       Date:  1990-11-21       Impact factor: 13.506

6.  Second malignancies in early stage laryngeal carcinoma patients treated with radiotherapy.

Authors:  John M Holland; Amir Arsanjani; Benny J Liem; S Christopher Hoffelt; James I Cohen; Kenneth R Stevens
Journal:  J Laryngol Otol       Date:  2002-03       Impact factor: 1.469

7.  Second primary head and neck squamous cell carcinoma predicted by the glutathione S-transferase expression in healthy tissue in the direct vicinity of the first tumor.

Authors:  V Bongers; G B Snow; N de Vries; A R Cattan; A G Hall; I van der Waal; B J Braakhuis
Journal:  Lab Invest       Date:  1995-10       Impact factor: 5.662

8.  Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States).

Authors:  Kim-Anh Do; Marcella M Johnson; Dorota A Doherty; J Jack Lee; Xi Feng Wu; Qiong Dong; Waun K Hong; Fadlo R Khuri; Karen K Fu; Margaret R Spitz
Journal:  Cancer Causes Control       Date:  2003-03       Impact factor: 2.506

9.  Second malignant neoplasia in patients with T1 glottic cancer treated with radiation.

Authors:  M Fujita; M S Rudoltz; D J Canady; P Patel; M Machtay; M Q Pittard; M Mohiuddin; W F Regine
Journal:  Laryngoscope       Date:  1998-12       Impact factor: 3.325

10.  Second primary tumors in patients with head and neck squamous cell carcinoma.

Authors:  A S Jones; P Morar; D E Phillips; J K Field; D Husband; T R Helliwell
Journal:  Cancer       Date:  1995-03-15       Impact factor: 6.860

View more
  13 in total

1.  FAS and FASLG genetic variants and risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck.

Authors:  Dapeng Lei; Erich M Sturgis; Li-E Wang; Zhensheng Liu; Mark E Zafereo; Qingyi Wei; Guojun Li
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-25       Impact factor: 4.254

2.  Evaluation of a biomarker based blood test for monitoring surgical resection of oral squamous cell carcinomas.

Authors:  Martin Grimm; Wiebke Kraut; Sebastian Hoefert; Michael Krimmel; Thorsten Biegner; Peter Teriete; Marcel Cetindis; Joachim Polligkeit; Susanne Kluba; Adelheid Munz; Siegmar Reinert
Journal:  Clin Oral Investig       Date:  2015-07-08       Impact factor: 3.573

3.  Generation of reactive oxygen species by grape seed extract causes irreparable DNA damage leading to G2/M arrest and apoptosis selectively in head and neck squamous cell carcinoma cells.

Authors:  Sangeeta Shrotriya; Gagan Deep; Mallikarjuna Gu; Manjinder Kaur; Anil K Jain; Swetha Inturi; Rajesh Agarwal; Chapla Agarwal
Journal:  Carcinogenesis       Date:  2012-01-19       Impact factor: 4.944

Review 4.  European Laryngological Society: ELS recommendations for the follow-up of patients treated for laryngeal cancer.

Authors:  Ricard Simo; Patrick Bradley; Dominique Chevalier; Frederik Dikkers; Hans Eckel; Nayla Matar; Giorgio Peretti; Cesare Piazza; Mark Remacle; Miquel Quer
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-09       Impact factor: 2.503

5.  Is there a patient population with squamous cell carcinoma of the head and neck region who might benefit from de-intensification of postoperative radiotherapy? : A monocentric retrospective analysis of a previously defined low-risk patient population treated with standard-of-care radiotherapy.

Authors:  Yonca Onbasi; Sebastian Lettmaier; Markus Hecht; Sabine Semrau; Heinrich Iro; Marco Kesting; Rainer Fietkau; Marlen Haderlein
Journal:  Strahlenther Onkol       Date:  2019-01-04       Impact factor: 3.621

6.  Grape seed extract targets mitochondrial electron transport chain complex III and induces oxidative and metabolic stress leading to cytoprotective autophagy and apoptotic death in human head and neck cancer cells.

Authors:  Sangeeta Shrotriya; Gagan Deep; Pamela Lopert; Manisha Patel; Rajesh Agarwal; Chapla Agarwal
Journal:  Mol Carcinog       Date:  2014-12-31       Impact factor: 4.784

7.  Genetic polymorphisms of p21 and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck.

Authors:  Dapeng Lei; Erich M Sturgis; Zhensheng Liu; Mark E Zafereo; Qingyi Wei; Guojun Li
Journal:  Carcinogenesis       Date:  2009-12-02       Impact factor: 4.944

8.  High expression of leucine zipper-EF-hand containing transmembrane protein 1 predicts poor prognosis in head and neck squamous cell carcinoma.

Authors:  Liyan Chen; Yang Yang; Shuangping Liu; Longzhen Piao; Yuan Zhang; Zhenhua Lin; Zhuhu Li
Journal:  Biomed Res Int       Date:  2014-02-05       Impact factor: 3.411

9.  Survival prognostic factors for metachronous second primary head and neck squamous cell carcinoma.

Authors:  Jin-Hua Chen; Yu-Chun Yen; Tsung-Ming Chen; Kevin Sheng-Po Yuan; Fei-Peng Lee; Kuan-Chou Lin; Ming-Tang Lai; Chia-Che Wu; Chia-Lun Chang; Szu-Yuan Wu
Journal:  Cancer Med       Date:  2016-12-17       Impact factor: 4.452

10.  First Clinical Report on Comparative Treatment and Survival Outcomes in Second Cancers after Primary Head and Neck Cancer: A Population-Based Study.

Authors:  Xin Wang; Elizabeth A Mauer; Paul Christos; Julia Manzerova; A Gabriella Wernicke; Bhupesh Parashar
Journal:  Cureus       Date:  2017-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.